The Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview
The CAN-PACT program focuses on psychedelic-assisted therapy cancer patients to address demoralization syndrome. This multi-phase initiative aims to improve supportive care for advanced cancer patients. It establishes clinical infrastructure and training…
Medical Marijuana for Management of Cancer Pain: A Narrative Review
This narrative review examines cannabis efficacy cancer pain management based on recent studies. It highlights the potential role of cannabinoids in oncology pain relief. Clinicians should consider cannabis as part of a multimodal approach to cancer pain.
Understanding Corticobasal Degeneration at Pacific Neuroscience Institute
Corticobasal degeneration neuroprotection is a critical area of research due to the disease's devastating progression. Cannabis shows promise in symptom management and neuroprotective effects for this rare disorder. Understanding these potentials can aid…
Review of Cannabinoids Safety and Efficacy in Pediatric Care
This review focuses on cannabinoids pediatric safety efficacy in clinical use, highlighting condition-specific evidence. Research supports cautious use in epilepsy and pain management among children. Clinicians should consider evolving data to guide…
5 Exciting Insights from the MedCan 3 Trial
MedCan 3: A Landmark Study on Medicinal Cannabis for Cancer Symptom Management Read The Study Publication The MedCan 3 study is a highly anticipated clinical trial investigating the potential of medicinal cannabis to alleviate symptoms in…
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer
Medical cannabis safety efficacy cancer was analyzed in a large cohort of patients with various cancer types. The study showed promising results in symptom relief and tolerability. This supports medical cannabis as a safe option for palliative care in…